Intralesional Vit. D as a cost effective modality for multiple warts: Case report

The cost effective approach for developing country ?

Authors

  • Dennis Henry Usha Memorial Skin and Eye Hospital, Bilaspur (Chhattisgarh), India.
  • Daniel Henry Usha Memorial Skin and Eye Hospital, Bilaspur (Chhattisgarh), India.

Keywords:

wart, immunotherapy, vitd

Abstract

Warts are a non-cancerous epidermal growth of the skin and mucosal membrane viral disease caused by human papillomavirus (HPV). Sudden clearance of lesions occurs under 24 months in about 80% of cases, people still look for a cure as it is cosmetically unpleasant and sometimes  Destructive treatment of warts is a majorly used, like topical keratolytic, electrosurgery, cryosurgery or lasers. These modalities prove to be ineffective in providing good aesthetic outcomes and avoiding recurrences. In a resource-limited setting, the cost of the treatment a crucial role in managing the patient of warts. Vitamin D comes up as one of the most affordable options for immunotherapy of the same. Few research papers have proven Vitamin D topical therapy to be effective.We report the response of multiple cutaneous warts to intralesional Vitamin D3 injections.

References

Sterling JC, Handfield-Jones S, Hudson PM. British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001;144:4–11

Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: Systematic review. BMJ. 2002;325:461.

Savant SS, Gore D. Electrosurgery. In: Savant SS, Shah RA, Gore D, editors. Textbook and Atlas of Dermatosurgery and Cosmetology. Mumbai: ASCAD; 2005. pp. 305–14.

Bourke JF, Berth-Jones J, Hutchinson PE. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br J Dermatol. 1995;132:433–6.

Tan OT, Hurwitz RM, Stafford TJ. Pulsed dye laser treatment of recalcitrant verrucae: A preliminary report. Lasers Surg Med. 1993;13:127–37.

Gonçalves MA, Donadi EA. Immune cellular response to HPV: Current concepts. Braz J Infect Dis. 2004;8:1–9.

Nofal A, Nofal E. Intralesional immunotherapy of common warts: Successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol. 2010;24:1166–70.

Shaheen MA, Salem SA, Fouad DA, El-Fatah AA. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: A comparative clinical and immunological study. Dermatol Ther. 2015;28:194–200.

Garg S, Baveja S. Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine. J Cutan Aesthet Surg. 2014;7:203–8.

Majid I, Imran S. Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: A study. Indian J Dermatol. 2013;58:360–5.

Rind T, Oiso N, Kawada A. Successful treatment of anogenital wart with a topical Vitamin D(3) Derivative in an infant. Case Rep Dermatol. 2010;2:46–49.

Imagawa I, Suzuki H. Successful treatment of refractory warts with topical Vitamin D3 derivative (maxacalcitol, 1alpha, 25-dihydroxy-22-oxacalcitriol) in 17 patients. J Dermatol. 2007;34:264–6.

Aktas H, Ergin C, Demir B, Ekiz Ö. Intralesional Vitamin D injection may be an effective treatment option for warts. J Cutan Med Surg. 2016;20:118–22.

Shalaby ME, Hasan MS, Elshorbagy MS, Abo Raya AR, Elsaie ML. Diagnostic and therapeutic implications of vitamin D deficiency in patients with warts: A case-controlled study. J Cosmet Dermatol. 2022 Mar;21(3):1135-1142. doi: 10.1111/jocd.14156. Epub 2021 Apr 25. PMID: 33860625.

Downloads

Published

2023-08-07

How to Cite

1.
Henry D, Henry D. Intralesional Vit. D as a cost effective modality for multiple warts: Case report: The cost effective approach for developing country ?. J Pak Assoc Dermatol [Internet]. 2023Aug.7 [cited 2024Jul.13];33(3):1137-9. Available from: http://www.jpad.com.pk/index.php/jpad/article/view/2290

Issue

Section

Case Reports